{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:42:21Z","timestamp":1784176941389,"version":"3.55.0"},"reference-count":189,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dazhou central hospital","award":["202208610036"],"award-info":[{"award-number":["202208610036"]}]},{"name":"Dazhou central hospital","award":["B02"],"award-info":[{"award-number":["B02"]}]},{"name":"CSC","award":["202208610036"],"award-info":[{"award-number":["202208610036"]}]},{"name":"CSC","award":["B02"],"award-info":[{"award-number":["B02"]}]},{"name":"DFG\/SFB1181","award":["202208610036"],"award-info":[{"award-number":["202208610036"]}]},{"name":"DFG\/SFB1181","award":["B02"],"award-info":[{"award-number":["B02"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Inflammatory bowel disease (IBD) is a group of disorders that cause chronic non-specific inflammation in the gastrointestinal (GI) tract, primarily affecting the ileum and colon. The incidence of IBD has risen sharply in recent years. Despite continuous research efforts over the past decades, the aetiology of IBD is still not fully understood and only a limited number of drugs are available for its treatment. Flavonoids, a ubiquitous class of natural chemicals found in plants, have been widely used in the prevention and treatment of IBD. However, their therapeutic efficacy is unsatisfactory due to poor solubility, instability, rapid metabolism, and rapid systemic elimination. With the development of nanomedicine, nanocarriers can efficiently encapsulate various flavonoids and subsequently form nanoparticles (NPs), which greatly improves the stability and bioavailability of flavonoids. Recently, progress has also been made in the methodology of biodegradable polymers that can be used to fabricate NPs. As a result, NPs can significantly enhance the preventive or therapeutic effects of flavonoids on IBD. In this review, we aim to evaluate the therapeutic effect of flavonoid NPs on IBD. Furthermore, we discuss possible challenges and future perspectives.<\/jats:p>","DOI":"10.3390\/ijms24054454","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T02:32:12Z","timestamp":1677205932000},"page":"4454","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Biodegradable Polymeric Nanoparticles Loaded with Flavonoids: A Promising Therapy for Inflammatory Bowel Disease"],"prefix":"10.3390","volume":"24","author":[{"given":"Mingrui","family":"Li","sequence":"first","affiliation":[{"name":"Department of Medicine 1, Kussmaul Campus for Medical Research, University of Erlangen-N\u00fcrnberg, 91052 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, Kussmaul Campus for Medical Research, University of Erlangen-N\u00fcrnberg, 91052 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2398-0844","authenticated-orcid":false,"given":"Benno","family":"Weigmann","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, Kussmaul Campus for Medical Research, University of Erlangen-N\u00fcrnberg, 91052 Erlangen, Germany"},{"name":"Medical Immunology Campus Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, 91052 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00535-021-01784-1","article-title":"Evidence-based clinical practice guidelines for inflammatory bowel disease 2020","volume":"56","author":"Nakase","year":"2021","journal-title":"J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1128\/CMR.15.1.79-94.2002","article-title":"Clinical aspects and pathophysiology of inflammatory bowel disease","volume":"15","author":"Hendrickson","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1132","article-title":"The immunological and genetic basis of inflammatory bowel disease","volume":"3","author":"Bouma","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S2468-1253(20)30299-5","article-title":"Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia","volume":"5","author":"Banerjee","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7247238","DOI":"10.1155\/2019\/7247238","article-title":"A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease","volume":"2019","author":"Guan","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Dolan, K.T., and Chang, E.B. (2017). Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases. Mol. Nutr. Food Res., 61.","DOI":"10.1002\/mnfr.201600129"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00535-005-1744-3","article-title":"Novel pathophysiological concepts of inflammatory bowel disease","volume":"41","author":"Hibi","year":"2006","journal-title":"J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2165\/00003495-200565160-00002","article-title":"Biologic therapy for inflammatory bowel disease","volume":"65","author":"Ardizzone","year":"2005","journal-title":"Drugs"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/ibd\/izz076","article-title":"Challenges in IBD Research: Environmental Triggers","volume":"25","author":"Ho","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000228553","article-title":"Environmental factors affecting inflammatory bowel disease: Have we made progress?","volume":"27","author":"Lakatos","year":"2009","journal-title":"Dig. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2019.11.003","article-title":"The microbiome and inflammatory bowel disease","volume":"145","author":"Glassner","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12328-017-0813-5","article-title":"Gut microbiota in the pathogenesis of inflammatory bowel disease","volume":"11","author":"Nishida","year":"2018","journal-title":"Clin. J. Gastroenterol."},{"key":"ref_14","first-page":"331","article-title":"The gut mycobiota: Insights into analysis, environmental interactions and role in gastrointestinal diseases","volume":"16","author":"Richard","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.suc.2007.03.005","article-title":"Immunologic and molecular mechanisms in inflammatory bowel disease","volume":"87","author":"Ince","year":"2007","journal-title":"Surg. Clin. N. Am."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"104892","DOI":"10.1016\/j.phrs.2020.104892","article-title":"Genetics and epigenetics of IBD","volume":"159","author":"Annese","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9346470","DOI":"10.1155\/2016\/9346470","article-title":"Bioactivity of Polyphenols: Preventive and Adjuvant Strategies toward Reducing Inflammatory Bowel Diseases-Promises, Perspectives, and Pitfalls","volume":"2016","author":"Kaulmann","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1039\/D0FO00713G","article-title":"Synergic interactions between polyphenols and gut microbiota in mitigating inflammatory bowel diseases","volume":"11","author":"Li","year":"2020","journal-title":"Food Funct."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"110018","DOI":"10.1016\/j.foodres.2020.110018","article-title":"Polyphenols from food by-products: An alternative or complementary therapy to IBD conventional treatments","volume":"140","author":"Machado","year":"2021","journal-title":"Food Res. Int."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Yu, C., Wang, D., Yang, Z., and Wang, T. (2022). Pharmacological Effects of Polyphenol Phytochemicals on the Intestinal Inflammation via Targeting TLR4\/NF-kappaB Signaling Pathway. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23136939"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Wan, J., Zhang, L., and Ruan, Z. (2022). Dietary Supplementation with Epicatechin Improves Intestinal Barrier Integrity in Mice. Foods, 11.","DOI":"10.3390\/foods11203301"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1080\/10408398.2015.1067595","article-title":"Advance on the Flavonoid C-glycosides and Health Benefits","volume":"56","author":"Xiao","year":"2016","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"100216","DOI":"10.18632\/oncotarget.22145","article-title":"Apigenin inhibits colonic inflammation and tumorigenesis by suppressing STAT3-NF-kappaB signaling","volume":"8","author":"Ai","year":"2017","journal-title":"Oncotarget"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"He, W., Li, Y., Liu, M., Yu, H., Chen, Q., Chen, Y., Ruan, J., Ding, Z., Zhang, Y., and Wang, T. (2018). Citrus aurantium L. and Its Flavonoids Regulate TNBS-Induced Inflammatory Bowel Disease through Anti-Inflammation and Suppressing Isolated Jejunum Contraction. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19103057"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5665778","DOI":"10.1155\/2022\/5665778","article-title":"Biological Activities Underlying the Therapeutic Effect of Quercetin on Inflammatory Bowel Disease","volume":"2022","author":"Lyu","year":"2022","journal-title":"Mediat. Inflamm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s40168-021-01115-9","article-title":"Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis","volume":"9","author":"Wu","year":"2021","journal-title":"Microbiome"},{"key":"ref_29","first-page":"1904","article-title":"A pilot study to evaluate the safety and efficacy of an oral dose of (-)-epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitis","volume":"19","author":"Dryden","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.3390\/nu5093367","article-title":"Flavonoid bioavailability and attempts for bioavailability enhancement","volume":"5","author":"Thilakarathna","year":"2013","journal-title":"Nutrients"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/biot.200700084","article-title":"Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health","volume":"2","author":"Ververidis","year":"2007","journal-title":"Biotechnol. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"162750","DOI":"10.1155\/2013\/162750","article-title":"Chemistry and biological activities of flavonoids: An overview","volume":"2013","author":"Kumar","year":"2013","journal-title":"Sci. World J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/138920021501140218125020","article-title":"Metabolism of flavonoids in human: A comprehensive review","volume":"15","author":"Chen","year":"2014","journal-title":"Curr. Drug Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.2174\/0929867325666180214121734","article-title":"Immunomodulatory Effects of Flavonoids in the Prophylaxis and Treatment of Inflammatory Bowel Diseases: A Comprehensive Review","volume":"25","author":"Ribeiro","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/nutrit\/nuu014","article-title":"Dietary flavonoids and nitrate: Effects on nitric oxide and vascular function","volume":"73","author":"Bondonno","year":"2015","journal-title":"Nutr. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF00797163","article-title":"Effect of quercitrin on structural changes in the large and small intestines in experimental enterocolitis","volume":"81","author":"Galsanov","year":"1976","journal-title":"Biull. Eksp. Biol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Li, M., and Weigmann, B. (2022). A Novel Pathway of Flavonoids Protecting against Inflammatory Bowel Disease: Modulating Enteroendocrine System. Metabolites, 12.","DOI":"10.3390\/metabo12010031"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s10620-006-9622-2","article-title":"Oxidative stress and pathogenesis of inflammatory bowel disease: An epiphenomenon or the cause?","volume":"52","author":"Rezaie","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00210-014-0985-1","article-title":"Review article: The role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases","volume":"387","author":"Fichna","year":"2014","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.3748\/wjg.v19.i39.6540","article-title":"Concepts of oxidative stress and antioxidant defense in Crohn\u2019s disease","volume":"19","author":"Alzoghaibi","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0891-5849(02)00853-5","article-title":"Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease","volume":"33","author":"Pavlick","year":"2002","journal-title":"Free Radic Biol. Med."},{"key":"ref_42","first-page":"417","article-title":"BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats","volume":"272","author":"Veljaca","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.3748\/wjg.v19.i34.5633","article-title":"Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats","volume":"19","author":"Abuohashish","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_44","first-page":"G795","article-title":"Nitric Oxide. III. A molecular prelude to intestinal inflammation","volume":"276","author":"Miller","year":"1999","journal-title":"Am. J. Physiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.bjp.0705941","article-title":"The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression","volume":"143","author":"Camuesco","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"643973","DOI":"10.3389\/fmed.2021.643973","article-title":"Intestinal Mucosal Wound Healing and Barrier Integrity in IBD-Crosstalk and Trafficking of Cellular Players","volume":"8","author":"Sommer","year":"2021","journal-title":"Front. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/acs.jafc.9b06294","article-title":"Protective Effect of Kaempferol on LPS-Induced Inflammation and Barrier Dysfunction in a Coculture Model of Intestinal Epithelial Cells and Intestinal Microvascular Endothelial Cells","volume":"68","author":"Bian","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00535-017-1384-4","article-title":"Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease","volume":"53","author":"Nishino","year":"2018","journal-title":"J. Gastroenterol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"715506","DOI":"10.3389\/fphys.2021.715506","article-title":"Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease","volume":"12","author":"Sultan","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00394-021-02489-0","article-title":"Diet supporting therapy for inflammatory bowel diseases","volume":"60","author":"Kikut","year":"2021","journal-title":"Eur. J. Nutr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"577237","DOI":"10.3389\/fphys.2020.577237","article-title":"Acacetin Ameliorates Experimental Colitis in Mice via Inhibiting Macrophage Inflammatory Response and Regulating the Composition of Gut Microbiota","volume":"11","author":"Ren","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"11503","DOI":"10.1039\/D1FO02454J","article-title":"Anti-inflammatory effects of purple sweet potato anthocyanin extract in DSS-induced colitis: Modulation of commensal bacteria and attenuated bacterial intestinal infection","volume":"12","author":"Mu","year":"2021","journal-title":"Food Funct."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"eabq4473","DOI":"10.1126\/scitranslmed.abq4473","article-title":"Targeting cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.intimp.2014.09.014","article-title":"Epigallocatechin-3-gallate sensitizes IFN-gamma-stimulated CD4+ T cells to apoptosis via alternative activation of STAT1","volume":"23","author":"Wu","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.bcp.2012.12.002","article-title":"Inhibition of Th1\/Th17 responses via suppression of STAT1 and STAT3 activation contributes to the amelioration of murine experimental colitis by a natural flavonoid glucoside icariin","volume":"85","author":"Tao","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"109315","DOI":"10.1016\/j.cbi.2020.109315","article-title":"Antioxidant and anti-inflammatory effects of hesperidin methyl chalcone in experimental ulcerative colitis","volume":"333","author":"Guazelli","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2013.06.007","article-title":"Involvement of JAK\/STAT signaling in the pathogenesis of inflammatory bowel disease","volume":"76","author":"Coskun","year":"2013","journal-title":"Pharmacol. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-kappaB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3748\/wjg.v20.i1.64","article-title":"Inflammatory pathways of importance for management of inflammatory bowel disease","volume":"20","author":"Pedersen","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3748\/wjg.14.200","article-title":"Role of the JNK signal transduction pathway in inflammatory bowel disease","volume":"14","author":"Roy","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.fitote.2016.07.016","article-title":"Flavonoids stimulate cholecystokinin peptide secretion from the enteroendocrine STC-1 cells","volume":"113","author":"Ravallec","year":"2016","journal-title":"Fitoterapia"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.redox.2017.11.002","article-title":"(-)-Epicatechin protects the intestinal barrier from high fat diet-induced permeabilization: Implications for steatosis and insulin resistance","volume":"14","author":"Cremonini","year":"2018","journal-title":"Redox Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1039\/C4FO00447G","article-title":"A grape seed extract increases active glucagon-like peptide-1 levels after an oral glucose load in rats","volume":"5","author":"Margalef","year":"2014","journal-title":"Food Funct."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Grau-Bove, C., Gonzalez-Quilen, C., Terra, X., Blay, M.T., Beltran-Debon, R., Jorba-Martin, R., Espina, B., Pinent, M., and Ardevol, A. (2020). Effects of Flavanols on Enteroendocrine Secretion. Biomolecules, 10.","DOI":"10.3390\/biom10060844"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Kato, M., Tani, T., Terahara, N., and Tsuda, T. (2015). The Anthocyanin Delphinidin 3-Rutinoside Stimulates Glucagon-Like Peptide-1 Secretion in Murine GLUTag Cell Line via the Ca2+\/Calmodulin-Dependent Kinase II Pathway. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0126157"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/gme.0b013e3181c92134","article-title":"Appetitive hormones, but not isoflavone tablets, influence overall and central adiposity in healthy postmenopausal women","volume":"17","author":"Matvienko","year":"2010","journal-title":"Menopause"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000217812","article-title":"Isoflavone reduces body weight by decreasing food intake in ovariectomized rats","volume":"54","author":"Zhang","year":"2009","journal-title":"Ann. Nutr. Metab."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.nano.2016.08.004","article-title":"GLP-1 nanomedicine alleviates gut inflammation","volume":"13","author":"Anbazhagan","year":"2017","journal-title":"Nanomedicine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1097\/MIB.0000000000000847","article-title":"GLP-1 Induces Barrier Protective Expression in Brunner\u2019s Glands and Regulates Colonic Inflammation","volume":"22","author":"Holm","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/ibd.21117","article-title":"Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn\u2019s disease","volume":"16","author":"Buchman","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"G1202","DOI":"10.1152\/ajpgi.90494.2008","article-title":"Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2","volume":"295","author":"Ivory","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Qi, K.K., Lv, J.J., Wu, J., and Xu, Z.W. (2017). Therapeutic effects of different doses of polyethylene glycosylated porcine glucagon-like peptide-2 on ulcerative colitis in male rats. BMC Gastroenterol., 17.","DOI":"10.1186\/s12876-017-0593-x"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1021\/acs.jmedchem.7b00768","article-title":"Stapled, Long-Acting Glucagon-like Peptide 2 Analog with Efficacy in Dextran Sodium Sulfate Induced Mouse Colitis Models","volume":"61","author":"Yang","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2982.2008.01184.x","article-title":"Endogenous and exogenous ghrelin enhance the colonic and gastric manifestations of dextran sodium sulphate-induced colitis in mice","volume":"21","author":"Thijs","year":"2009","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1053\/j.gastro.2006.01.041","article-title":"Therapeutic action of ghrelin in a mouse model of colitis","volume":"130","author":"Chorny","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_77","first-page":"41","article-title":"Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves","volume":"60","author":"Konturek","year":"2009","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/eji.201343725","article-title":"CCK8 negatively regulates the TLR9-induced activation of human peripheral blood pDCs by targeting TRAF6 signaling","volume":"44","author":"Jia","year":"2014","journal-title":"Eur J. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1097\/CCM.0b013e3181eb90d7","article-title":"Lipid-enriched enteral nutrition controls the inflammatory response in murine Gram-negative sepsis","volume":"38","author":"Lubbers","year":"2010","journal-title":"Crit. Care Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/CCM.0b013e31827c0a17","article-title":"Continuous administration of enteral lipid- and protein-rich nutrition limits inflammation in a human endotoxemia model","volume":"41","author":"Lubbers","year":"2013","journal-title":"Crit. Care Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/SHK.0000000000001355","article-title":"Cholecystokinin Modulates the Mucosal Inflammatory Response and Prevents the Lipopolysaccharide-Induced Intestinal Epithelial Barrier Dysfunction","volume":"53","author":"Saia","year":"2020","journal-title":"Shock"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3748\/wjg.v24.i8.877","article-title":"Regulation of the intestinal immune system by flavonoids and its utility in chronic inflammatory bowel disease","volume":"24","author":"Hoensch","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s10753-014-0083-z","article-title":"IL-22 Up-Regulates beta-Defensin-2 Expression in Human Alveolar Epithelium via STAT3 but Not NF-kappaB Signaling Pathway","volume":"38","author":"Li","year":"2015","journal-title":"Inflammation"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1016\/j.bmc.2015.04.025","article-title":"Promiscuity and selectivity of bitter molecules and their receptors","volume":"23","author":"Niv","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.mad.2004.06.011","article-title":"Alterations in stomach ghrelin production and in ghrelin-induced growth hormone secretion in the aged rat","volume":"125","author":"Englander","year":"2004","journal-title":"Mech. Ageing Dev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1002\/mnfr.201600242","article-title":"Subchronic treatment with grape-seed phenolics inhibits ghrelin production despite a short-term stimulation of ghrelin secretion produced by bitter-sensing flavanols","volume":"60","author":"Serrano","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1208\/s12249-011-9672-4","article-title":"Enhanced intestinal absorption of daidzein by borneol\/menthol eutectic mixture and microemulsion","volume":"12","author":"Shen","year":"2011","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1021\/mp700071d","article-title":"Methylation of dietary flavones greatly improves their hepatic metabolic stability and intestinal absorption","volume":"4","author":"Walle","year":"2007","journal-title":"Mol. Pharm."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/jn\/136.2.404","article-title":"Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: A randomized, double-blind, crossover trial","volume":"136","author":"Nielsen","year":"2006","journal-title":"J. Nutr."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fphar.2018.00027","article-title":"Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types","volume":"9","author":"Kou","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.1039\/C8CS00162F","article-title":"Liposomes and polymersomes: A comparative review towards cell mimicking","volume":"47","author":"Rideau","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41565-018-0342-5","article-title":"Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy","volume":"14","author":"Shae","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1073\/pnas.1916395117","article-title":"Organelle-specific targeting of polymersomes into the cell nucleus","volume":"117","author":"Zelmer","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.actbio.2019.10.003","article-title":"Effects of cartilage-targeting moieties on nanoparticle biodistribution in healthy and osteoarthritic joints","volume":"101","author":"Brown","year":"2020","journal-title":"Acta Biomater."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.actbio.2019.12.005","article-title":"siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery","volume":"103","author":"He","year":"2020","journal-title":"Acta Biomater."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"42186","DOI":"10.1021\/acsami.8b18979","article-title":"Hydrogen-Bonded Tannic Acid-Based Anticancer Nanoparticle for Enhancement of Oral Chemotherapy","volume":"10","author":"Le","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12951-019-0451-9","article-title":"Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats","volume":"17","author":"Zhang","year":"2019","journal-title":"J. Nanobiotechnol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"110768","DOI":"10.1016\/j.msec.2020.110768","article-title":"Microfluidic-assisted polymer-protein assembly to fabricate homogeneous functionalnanoparticles","volume":"111","author":"Zhang","year":"2020","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijpharm.2019.03.011","article-title":"Natural biodegradable polymers based nano-formulations for drug delivery: A review","volume":"561","author":"George","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijpharm.2013.07.034","article-title":"Chitosan nanoparticles: Preparation, size evolution and stability","volume":"455","author":"Rampino","year":"2013","journal-title":"Int J. Pharm."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Zhao, D., Yu, S., Sun, B., Gao, S., Guo, S., and Zhao, K. (2018). Biomedical Applications of Chitosan and Its Derivative Nanoparticles. Polymers, 10.","DOI":"10.3390\/polym10040462"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/jps.23470","article-title":"Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N\u2019-octyl chitosan micelles","volume":"102","author":"Zhu","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.sjbs.2020.05.023","article-title":"A Chitosan-PLGA based catechin hydrate nanoparticles used in targeting of lungs and cancer treatment","volume":"27","author":"Ahmad","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"De Marco, I. (2022). Zein Microparticles and Nanoparticles as Drug Delivery Systems. Polymers, 14.","DOI":"10.3390\/polym14112172"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1208\/s12249-018-1035-y","article-title":"Zein as a Pharmaceutical Excipient in Oral Solid Dosage Forms: State of the Art and Future Perspectives","volume":"19","author":"Berardi","year":"2018","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1039\/C5FO00422E","article-title":"Amphiphilic zein hydrolysate as a novel nano-delivery vehicle for curcumin","volume":"6","author":"Wang","year":"2015","journal-title":"Food Funct."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.foodchem.2018.10.034","article-title":"Zein-hyaluronic acid binary complex as a delivery vehicle of quercetagetin: Fabrication, structural characterization, physicochemical stability and in vitro release property","volume":"276","author":"Chen","year":"2019","journal-title":"Food Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.2174\/1381612822666160510125718","article-title":"Alginate Based Nanocarriers for Drug Delivery Applications","volume":"22","author":"Jana","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jconrel.2006.06.011","article-title":"Uptake studies in rat Peyer\u2019s patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination","volume":"114","author":"Borges","year":"2006","journal-title":"J. Control. Release"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijbiomac.2014.05.036","article-title":"Alginate\/chitosan nanoparticles for encapsulation and controlled release of vitamin B2","volume":"71","author":"Azevedo","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.vaccine.2019.11.031","article-title":"An overview of biodegradable nanomaterials and applications in vaccines","volume":"38","author":"Yan","year":"2020","journal-title":"Vaccine"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ijbiomac.2019.10.060","article-title":"Facile preparation of hyaluronic acid-based quercetin nanoformulation for targeted tumor therapy","volume":"147","author":"Xiong","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.colsurfb.2014.03.017","article-title":"Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly(d,l-lactide-co-glycolic acid) and polyalkylcyanoacrylate","volume":"118","author":"Lai","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev-chembioeng-060817-084055","article-title":"Biodegradable Polymeric Nanoparticles for Therapeutic Cancer Treatments","volume":"9","author":"Karlsson","year":"2018","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1163\/156856206775997322","article-title":"Synthesis and characterization of PLGA nanoparticles","volume":"17","author":"Astete","year":"2006","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.msec.2017.12.036","article-title":"Recent advances of PLGA micro\/nanoparticles for the delivery of biomacromolecular therapeutics","volume":"92","author":"Ding","year":"2018","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"113887","DOI":"10.1016\/j.addr.2021.113887","article-title":"Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases","volume":"176","author":"Zu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.2147\/IJN.S146296","article-title":"In vitro study on anti-inflammatory effects of epigallocatechin-3-gallate-loaded nano- and microscale particles","volume":"12","author":"Wu","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2015.11.033","article-title":"Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin","volume":"138","author":"Chen","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2017.05.028","article-title":"PEG-PCL-based nanomedicines: A biodegradable drug delivery system and its application","volume":"260","author":"Grossen","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1039\/C4BM00242C","article-title":"mRNA delivery using non-viral PCL nanoparticles","volume":"3","author":"Palama","year":"2015","journal-title":"Biomater. Sci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s13346-021-00917-6","article-title":"Quercetin-biapigenin nanoparticles are effective to penetrate the blood-brain barrier","volume":"12","author":"Oliveira","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1080\/09205063.2015.1095023","article-title":"epsilon-Polylysine and next-generation dendrigraft poly-L-lysine: Chemistry, activity, and applications in biopharmaceuticals","volume":"26","author":"Shi","year":"2015","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1021\/acs.jcim.7b00258","article-title":"Digitizing Poly-l-lysine Dendrigrafts: From Experimental Data to Molecular Dynamics Simulations","volume":"57","author":"Francoia","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Zhao, K., Li, D., Cheng, G., Zhang, B., Han, J., Chen, J., Wang, B., Li, M., Xiao, T., and Zhang, J. (2019). Targeted Delivery Prodigiosin to Choriocarcinoma by Peptide-Guided Dendrigraft Poly-l-lysines Nanoparticles. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215458"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0169-409X(02)00050-9","article-title":"Polyanhydrides: An overview","volume":"54","author":"Kumar","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.2147\/IJN.S261041","article-title":"Polyanhydride Nanoparticles Induce Low Inflammatory Dendritic Cell Activation Resulting in CD8(+) T Cell Memory and Delayed Tumor Progression","volume":"15","author":"Darling","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ijbiomac.2016.10.094","article-title":"Thiolated methylated dimethylaminobenzyl chitosan: A novel chitosan derivative as a potential delivery vehicle","volume":"95","author":"Hakimi","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/17425247.2016.1214564","article-title":"Preparation methods and applications behind alginate-based particles","volume":"14","author":"Lopes","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2015.04.010","article-title":"Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens","volume":"208","author":"Fan","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/0885328216669475","article-title":"Production and characterization of hyaluronic acid microparticles for the controlled delivery of growth factors using a spray\/dehydration method","volume":"31","author":"Babo","year":"2016","journal-title":"J. Biomater. Appl."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/21645515.2015.1117714","article-title":"PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity","volume":"12","author":"Silva","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2147\/IJN.S40579","article-title":"Concepts and practices used to develop functional PLGA-based nanoparticulate systems","volume":"8","author":"Sah","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/chem.200901734","article-title":"An expeditious multigram-scale synthesis of lysine dendrigraft (DGL) polymers by aqueous N-carboxyanhydride polycondensation","volume":"16","author":"Collet","year":"2010","journal-title":"Chemistry"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/jbm.a.36128","article-title":"Functionalization promotes pathogen-mimicking characteristics of polyanhydride nanoparticle adjuvants","volume":"105","author":"Phanse","year":"2017","journal-title":"J. Biomed. Mater. Res. A"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e1706815","DOI":"10.1002\/adma.201706815","article-title":"Recent Advances in Polyanhydride Based Biomaterials","volume":"30","author":"Basu","year":"2018","journal-title":"Adv. Mater."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"6491","DOI":"10.1021\/acsnano.8b09679","article-title":"Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo","volume":"13","author":"Nguyen","year":"2019","journal-title":"ACS Nano"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"17063","DOI":"10.1021\/ja2075345","article-title":"Pre- and postfunctionalized self-assembled pi-conjugated fluorescent organic nanoparticles for dual targeting","volume":"133","author":"Petkau","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Jacob, E.M., Borah, A., Pillai, S.C., and Kumar, D.S. (2020). Inflammatory Bowel Disease: The Emergence of New Trends in Lifestyle and Nanomedicine as the Modern Tool for Pharmacotherapy. Nanomaterials, 10.","DOI":"10.3390\/nano10122460"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s40199-018-0222-4","article-title":"A systematic review of nano formulation of natural products for the treatment of inflammatory bowel disease: Drug delivery and pharmacological targets","volume":"26","author":"Taghipour","year":"2018","journal-title":"Daru"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jconrel.2014.03.039","article-title":"Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases","volume":"183","author":"Ali","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nmat2859","article-title":"Orally delivered thioketal nanoparticles loaded with TNF-alpha-siRNA target inflammation and inhibit gene expression in the intestines","volume":"9","author":"Wilson","year":"2010","journal-title":"Nat. Mater."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1039\/D0TB02092C","article-title":"Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues","volume":"9","author":"Huang","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.nano.2015.02.018","article-title":"Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissue","volume":"11","author":"Hua","year":"2015","journal-title":"Nanomedicine"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.nantod.2017.08.006","article-title":"Nanoparticulate Drug Delivery Systems Targeting Inflammation for Treatment of Inflammatory Bowel Disease","volume":"16","author":"Zhang","year":"2017","journal-title":"Nano Today"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2019.12.001","article-title":"Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases","volume":"165","author":"He","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrgastro.2010.66","article-title":"IBD: Selective nanoparticle adhesion can enhance colitis therapy","volume":"7","author":"Lamprecht","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1016\/j.biomaterials.2013.01.079","article-title":"Galactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/ibd\/izy123","article-title":"Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis","volume":"24","author":"Zhang","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"8875","DOI":"10.2147\/IJN.S210315","article-title":"Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives","volume":"14","author":"Yang","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"120935","DOI":"10.1016\/j.ijpharm.2021.120935","article-title":"Silk fibroin nanoparticles enhance quercetin immunomodulatory properties in DSS-induced mouse colitis","volume":"606","author":"Vezza","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Khater, S.I., Lotfy, M.M., Alandiyjany, M.N., Alqahtani, L.S., Zaglool, A.W., Althobaiti, F., Ismail, T.A., Soliman, M.M., Saad, S., and Ibrahim, D. (2022). Therapeutic Potential of Quercetin Loaded Nanoparticles: Novel Insights in Alleviating Colitis in an Experimental DSS Induced Colitis Model. Biomedicines, 10.","DOI":"10.3390\/biomedicines10071654"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/acs.molpharmaceut.0c01245","article-title":"Smart Responsive Quercetin-Conjugated Glycol Chitosan Prodrug Micelles for Treatment of Inflammatory Bowel Diseases","volume":"18","author":"Shen","year":"2021","journal-title":"Mol. Pharm."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"969962","DOI":"10.3389\/fchem.2022.969962","article-title":"Apigenin-Mn(II) loaded hyaluronic acid nanoparticles for ulcerative colitis therapy in mice","volume":"10","author":"Lv","year":"2022","journal-title":"Front. Chem."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejps.2010.06.010","article-title":"Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate","volume":"41","author":"Dube","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejps.2011.09.004","article-title":"Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability","volume":"44","author":"Dube","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1021\/jf404621f","article-title":"Fabrication of self-assembled (-)-epigallocatechin gallate (EGCG) ovalbumin-dextran conjugate nanoparticles and their transport across monolayers of human intestinal epithelial Caco-2 cells","volume":"62","author":"Li","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jconrel.2022.05.025","article-title":"Oral antimicrobial peptide-EGCG nanomedicines for synergistic treatment of ulcerative colitis","volume":"347","author":"Liu","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cbi.2016.07.012","article-title":"PVP- coated naringenin nanoparticles for biomedical applications - In vivo toxicological evaluations","volume":"257","author":"Kumar","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1248\/bpb.b14-00508","article-title":"Enhanced oral bioavailability of morin administered in mixed micelle formulation with PluronicF127 and Tween80 in rats","volume":"38","author":"Choi","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Li, Y., Yao, J., Han, C., Yang, J., Chaudhry, M.T., Wang, S., Liu, H., and Yin, Y. (2016). Quercetin, Inflammation and Immunity. Nutrients, 8.","DOI":"10.3390\/nu8030167"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"201700447","DOI":"10.1002\/mnfr.201700447","article-title":"Safety Aspects of the Use of Quercetin as a Dietary Supplement","volume":"62","author":"Andres","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.2174\/1389201021666200711152726","article-title":"Dietary Quercetin Alleviated DSS-induced Colitis in Mice Through Several Possible Pathways by Transcriptome Analysis","volume":"21","author":"Dong","year":"2020","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3389\/fmicb.2019.01092","article-title":"Dietary Quercetin Increases Colonic Microbial Diversity and Attenuates Colitis Severity in Citrobacter rodentium-Infected Mice","volume":"10","author":"Lin","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4103\/1673-5374.162686","article-title":"Curcumin and Apigenin\u2014Novel and promising therapeutics against chronic neuroinflammation in Alzheimer\u2019s disease","volume":"10","author":"Venigalla","year":"2015","journal-title":"Neural. Regen. Res."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Salehi, B., Venditti, A., Sharifi-Rad, M., Kregiel, D., Sharifi-Rad, J., Durazzo, A., Lucarini, M., Santini, A., Souto, E.B., and Novellino, E. (2019). The Therapeutic Potential of Apigenin. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061305"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.nutr.22.111401.144957","article-title":"Dietary flavonoids: Bioavailability, metabolic effects, and safety","volume":"22","author":"Ross","year":"2002","journal-title":"Annu. Rev. Nutr."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.fitote.2011.06.008","article-title":"Use of apigenin from Cordia dichotoma in the treatment of colitis","volume":"82","author":"Ganjare","year":"2011","journal-title":"Fitoterapia"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.yrtph.2018.03.019","article-title":"The safety of green tea and green tea extract consumption in adults\u2014Results of a systematic review","volume":"95","author":"Hu","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Kochman, J., Jakubczyk, K., Antoniewicz, J., Mruk, H., and Janda, K. (2020). Health Benefits and Chemical Composition of Matcha Green Tea: A Review. Molecules, 26.","DOI":"10.3390\/molecules26010085"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.lfs.2018.10.066","article-title":"Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update","volume":"215","author":"Joshi","year":"2018","journal-title":"Life Sci."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/dom.13868","article-title":"Safety and pharmacokinetics of naringenin: A randomized, controlled, single-ascending-dose clinical trial","volume":"22","author":"Rebello","year":"2020","journal-title":"Diabetes Obes. Metab."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Salehi, B., Fokou, P.V.T., Sharifi-Rad, M., Zucca, P., Pezzani, R., Martins, N., and Sharifi-Rad, J. (2019). The Therapeutic Potential of Naringenin: A Review of Clinical Trials. Pharmaceuticals, 12.","DOI":"10.3390\/ph12010011"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.nutres.2019.01.004","article-title":"Naringenin promotes recovery from colonic damage through suppression of epithelial tumor necrosis factor-alpha production and induction of M2-type macrophages in colitic mice","volume":"64","author":"Chaen","year":"2019","journal-title":"Nutr. Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jnutbio.2019.03.009","article-title":"Synergistic anti-inflammatory effects and mechanisms of combined phytochemicals","volume":"69","author":"Zhang","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1093\/carcin\/bgn182","article-title":"Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate","volume":"29","author":"Lambert","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jnutbio.2015.01.002","article-title":"Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats","volume":"26","author":"Etxeberria","year":"2015","journal-title":"J. Nutr. Biochem."},{"key":"ref_181","first-page":"24","article-title":"Polyphenols: A first evidence in the synergism and bioactivities","volume":"1","author":"Mitra","year":"2022","journal-title":"Food Rev. Int."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ptr.6268","article-title":"Synergistic anti-inflammatory effects of quercetin and catechin via inhibiting activation of TLR4-MyD88-mediated NF-kappaB and MAPK signaling pathways","volume":"33","author":"Li","year":"2019","journal-title":"Phytother. Res."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ijpharm.2014.10.070","article-title":"Nanonization of curcumin by antisolvent precipitation: Process development, characterization, freeze drying and stability performance","volume":"477","author":"Yadav","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.addr.2020.07.010","article-title":"Advanced nanomedicines for the treatment of inflammatory diseases","volume":"157","author":"Brusini","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2014.12.030","article-title":"Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications","volume":"200","author":"Wicki","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jpba.2018.06.002","article-title":"Natural deep eutectic solvents as eco-friendly and sustainable dilution medium for the determination of residual organic solvents in pharmaceuticals with static headspace-gas chromatography","volume":"158","author":"Wang","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.tibtech.2008.03.004","article-title":"New opportunities for biocatalysis: Making pharmaceutical processes greener","volume":"26","author":"Woodley","year":"2008","journal-title":"Trends. Biotechnol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jconrel.2020.01.047","article-title":"Macrophage-based nanotherapeutic strategies in ulcerative colitis","volume":"320","author":"Zhang","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.drudis.2021.03.005","article-title":"Neoteric solvents for the pharmaceutical industry: An update","volume":"26","author":"Sekharan","year":"2021","journal-title":"Drug Discov. Today"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/5\/4454\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:41:02Z","timestamp":1760121662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/5\/4454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":189,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["ijms24054454"],"URL":"https:\/\/doi.org\/10.3390\/ijms24054454","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]}}}